Peter D Verhaert
Prof. Dr. Peter D.E.M. Verhaert (Belgium, 1961) is founder and CEO/CSO of ProteoFormiX (www.proteoformix.com).
He is honorary professor Mass Spectrometry Histochemistry at the Maastricht Multimodal Molecular Imaging Institute (M4i) of Maastricht University since 2017.
Chair “Analytical Biotechnology and Innovative Peptide Biology” at Delft University of Technology (2005 – 2016).
Sabbatical at Antwerp University (Department of Biology) and at the Faculty of Medicine (Clinical Sciences Department) of Lund University, where he co-directed the Center of Excellence in Biomedical Mass Spectrometry (CEBMMS) (2016).
Visiting professor at the Biomedical Research Institute of Hasselt University (2004-2014).
Group Leader Proteomics at Organon and proteomics expert at the Flemish Institute of Biotechnology (VIB) (2000-2004).
Senior Research Associate of the Flemish Fund for Scientific Research (Universities of Leuven and Liège) (1983-1999).
Sabbat year at Innogenetics (1998-99).
Co-founder and president of the European Pharmaceutical Proteomics Laboratories (EPPL).
Former Editor-in-chief of the Elsevier Open Access Journal EuPA Open Proteomics’
Postdoctoral year at the University of Waterloo (Ontario, Canada).
PhD in Biology (Zoology Group) from the University of Leuven (1987).
Abstracts this author is presenting: